Alpine Global Management, LLC
Position in ALNY — Alnylam Pharmaceuticals, Inc.
CIK 1581655
NEW YORK, NY
Position in ALNY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$441,611
+$138,204 QoQ
Shares Held
1,467
+60.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#495
of 784 holders
Holding Since
Dec 2021
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Alpine Global Management, LLC holds $66,598,591 across 8 Biotechnology names. ALNY ranks #6 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IMVT |
Immunovant, Inc.
|
1,375,000 | $52,978,750 | |
| 2 | APGE |
Apogee Therapeutics, Inc.
|
32,500 | $4,313,725 | |
| 3 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
6,033 | $3,239,419 | |
| 4 | TECH |
BIO-TECHNE Corp
|
40,000 | $2,826,000 | |
| 5 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
33,339 | $2,717,461 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
1,467 | $441,611 | |
| 7 | ACHV |
Achieve Life Sciences, Inc.
|
12,500 | $81,625 | |
| 8 | 1,643 | $0 |
All Filings in ALNY
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $441,611 | 1,467 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $303,407 | 917 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $819,954 | 2,062 | Shares | Sole | 2026-02-26 | |
| 2021-12-31 | $1,074,119 | 6,334 | Shares | Sole | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||